THCV is the cannabinoid marketed as "diet weed," and that nickname is where the honesty has to start. Its appetite and weight effects come from mice; the one human trial that measured them found nothing. It is also not simply non-intoxicating, its effect flips with dose. A genuinely interesting molecule that is easy to oversell.
Where it stands legally
None.
Where the evidence stands
Ranked by how much each finding can actually tell you, strongest first. A trial in people outranks a study in cells, including when the answer is no.
Human trial
Modestly lowered fasting blood glucose in type-2 diabetes (pilot)
THCV (5 mg twice daily, 13 weeks) lowered fasting glucose and improved β-cell markers vs placebo. But it MISSED its primary endpoint (HDL), the THCV arm was tiny (~11–13 people), it has never been replicated, and it found NO effect on appetite or body weight. Non-psychoactive at this dose. Jadoon KA, Ratcliffe SH, Barrett DA, et al. (2016). Diabetes Care, 39:1777–1786. PubMed 27573936
Human trial · not established
"Diet weed": suppresses appetite and causes weight loss
The appetite/weight effect is from mouse studies. The single human trial measured appetite and body weight and found NO significant THCV effect on either.
Animal studies
Improved insulin sensitivity in obese mice, without weight loss
The mechanistic basis for the diabetes pilot. Notably the metabolic benefit came WITHOUT reducing food intake or body weight in these mice. Wargent ET, Zaibi MS, Silvestri C, et al. (2013). Nutrition & Diabetes, 3:e68. PubMed 23712280
Animal studies
Acts differently at low vs high dose (not simply "non-psychoactive")
THCV blocks CB1 at low doses (so it is non-intoxicating there, and can even blunt THC) but can act as a CB1 agonist at higher doses. "Always non-psychoactive" is an overstatement. It is dose-dependent, and no human intoxication threshold has been defined. Pertwee RG, Thomas A, Stevenson LA, et al. (2007). British Journal of Pharmacology, 150:586–594. PubMed 17245367
Animal studies · not established
Treats epilepsy or Parkinson’s in people
Anticonvulsant and Parkinson’s findings are rodent-only. Unlike CBD for epilepsy, THCV has zero human clinical data here.
No published study · still open
A proven treatment for diabetes
One small pilot that missed its primary endpoint and was never replicated. Hypothesis-generating, not established.
No published study · still open
Completely non-psychoactive
True only at low doses; its CB1 effect flips with dose in animals, and no human threshold is defined.
Chemical identity, formula and molar mass: PubChem CID 93147, National Center for Biotechnology Information.
Terpenology is educational, not medical advice. Cannabinoid effects are tendencies reported by patients and early research, never guaranteed outcomes. Work with your certifying physician and pharmacist.